The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study

BACKGROUND: Dopamine agonists (DA) are the first-choice drug for treatment of the early stage of Parkinson’s disease (PD) in subjects younger than 70 years. Recently, a number of third generation DA have been marketed, including transdermal patch of rotigotine and extended release oral formulation o...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Pellicano, Clelia, Benincasa, Dario, Fanciulli, Alessandra, Latino, Pamela, Giovannelli, Morena, Pontieri, Francesco E
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880455/
https://ncbi.nlm.nih.gov/pubmed/24360350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-18-60
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items